Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis

Journal of Clinical Microbiology

Volumn 43, Issue 1, 2005, Pages 140-143

  Orhan, Gani ^a   Bayram, Aysen ^a   Zer, Yasemin ^a   Balci, Iclal ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; RIFAPRIM; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BRUCELLA MELITENSIS; BRUCELLOSIS; DRUG EFFECT; INTERMETHOD COMPARISON; ISOLATION AND PURIFICATION; LABORATORY TEST; MICROTITER PLATE ASSAY; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BRUCELLA MELITENSIS; BRUCELLOSIS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MICROBIAL SENSITIVITY TESTS;

BACTERIA (MICROORGANISMS); BRUCELLA; BRUCELLA MELITENSIS; NEGIBACTERIA;

EID: 11844299071     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.1.140-143.2005     Document Type: Article

References (19)

1. Akalin, H. E., E. Tümbay, S. Hilmi, and Ö. Anǧ. 1991. Brucella and brucellosis in man and animals, p. 123-130. Turkish Microbiological Society, Istanbul, Turkey.
2. Akova, M. 2001. Brusellozis tedavisi. Ankem Dergisi. 15:575-576.
3. Bajaksouzian, S., M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum. 1997. Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies. Antimicrob. Agents Chemother. 41:1073-1076.
4. Baysal B. 1991. Brusella, p. 571-577. In Ş. Ustaçelebi, G. Mutlu, T. İmir, A. T. Cengiz, E. Tümbay, and Ö Mete (ed.), Temel ve klinik mikrobiyoloji. Günes Kitapevi, Ankara, Turkey.
5. Bonapace, C. R., R. L. White, L. V. Friedrich, and J. A. Bosso. 2000. Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with E-test, time-kill, and checkerboard methods. Diagn. Microbiol. Infect. Dis. 38:43-50.
6. Cercenado, E., F. Garcia-Garotte, and E. Bouza. 1996. Activity of different antimicrobial combinations against methicillin-and teicoplanin-resistant coagulase-negative staphylococci: utility of the E-test for the determination of the effects of antimicrobial combinations, p. 209. Abstr. 39th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, D.C.
7. Cercenado, E., F. Garcia-Garotte, and E. Bouza. 1996. Effect of linezolid with vancomycin against highly vancomycin resistant enterococci: utility of the E-test for the determination of the effects of antimicrobial combinations, p. 210. Abstr. 39th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, D.C.
8. Çevik, M. A. 2001. Brucelloz epidemiyolojisi. Ankem Dergisi. 15:568-570.
9. Göksel S. 2001. Çoklu dirençli Pseudomonas aeruginosa kökenlerinde meropenem-amikasin ve meropenem-siprofloksasin kombinasyonlarinin invitro sinerjik etkinliklerinin aråtirilmasi. Ege Üniversitesi Tip Fakültesi Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dali Uzmanlik Tezi, İzmir, Turkey.
10. Gür, D., Ç. Bal, and G. Söyletir. 2001. Antibiyotik duyarlilik testleri için uygulama standartlari onbirinci bilgi eki, p. 114. Bilimsel Tip Yayinevi, Ankara, Turkey.
11. Gutuzo, E., and C. Carrillo. 1998. Brucella, p. 1837. In S. L. Gorbach, J. G. Bartlett, and N. R. Blacklow (ed.), Infectious diseases, 2nd ed. The W. B. Saunders Company, Philadelphia, Pa.
12. Kobayashi, Y., M. Kizaki, A. Mutou, et al. 1997. Synergy with imipenem, panipenem or meropenem and vancomycin against carbapenem resistant MRSA detected by two different methods. 20th Int. Conf. Chemother., abstr. 2297.
13. Özsüt, H. 1990. Bruselloz tedavisi. Klimik Dergisi. 3:26-29.
14. Öztürk, R. 1997. Antibiyotik duyarlilik testlerinde sorunlar. Brucella: antibiyotik duyarlilik testlerinin standardizasyon toplantisi, p. 56-64. Türk Mikrobiyoloji Cemiyeti Yayinlari, İstanbul, Turkey.
15. Roux, J. 1991. Public health importance of brucellosis, p. 3-10. In E. Tümbay, S. Hilmi, and Ö. Anǧ (ed.), Brucella and brucellosis in man and animals. Turkish Microbiological Society, Istanbul, Turkey.
16. Sözen, T. H. 1996. Bruselloz, p. 486-491. In A. Willke, G. Söyletir, and M. Doganay (ed.), İnfeksiyon Hastaliklari. Nobel Tip Kitapevi, Istanbul, Turkey.
17. Sümerkan, B. 2001. Brucella bakterilerinde in-vitro antibiyotik duyarliliǧi. Ankem Dergisi. 15:571-574.
18. White, R. L., D. S. Burgess, M. Manduru, and J. A. Bosso. 1996. Comparison of three different in vitro methods of detecting synergy: time-kill, checker-board and E-test. Antimicrob. Agents Chemother. 40:1914-1918.
19. Young, E. J. 2000. Brucella species, p. 2386-2393. In G. Mandell, J. I. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, vol. 2. Churchill Livingstone, New York, N.Y.